Datasets:
sovai
/
lobbying_data

Dataset card Data Studio Files
xet
Community
ticker
stringlengths
1
10
date
timestamp[ns]
client
stringlengths
1
80
client_description
stringlengths
2
114
⌀
spend
float64
0
25.9M
transaction_type
stringclasses
7 values
filing_type
stringclasses
7 values
lobby_description
listlengths
0
34
issue_codes
listlengths
1
34
⌀
government_entity_details
listlengths
1
725
⌀
quarter
stringclasses
66 values
effective_date
stringlengths
10
10
termination_date
stringlengths
10
10
⌀
client_state
stringclasses
56 values
client_country
stringclasses
40 values
client_id
int64
12
10M
government_lobby
float64
0
1
⌀
performing_own_lobbying
float64
0
1
⌀
registrant_dt_updated
stringlengths
32
32
registrant_name
stringlengths
3
99
registrant_address
stringlengths
32
87
registrant_id
int64
33
401M
registrant_description
stringlengths
2
103
⌀
registrant_contact_name
stringlengths
0
34
registrant_house_registrant_id
float64
12.7k
401M
⌀
registrant_contact_telephone
stringlengths
0
16
lobbyist_full_names
listlengths
1
272
⌀
lobbyist_ids
listlengths
1
272
⌀
previous_goverment_positions
listlengths
1
272
⌀
lobbyist_new_statuses
listlengths
1
272
⌀
client_url
stringlengths
44
45
registrant_url
stringlengths
45
52
filing_url
stringlengths
88
88
filing_id
stringlengths
36
36
unique_id
stringlengths
46
53
match
stringlengths
1
80
date_time
timestamp[ns]
45774N10
2014-01-15T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2013-Q4
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/6e6616d3-9007-486b-a419-74fdc8f92754/print/
6e6616d3-9007-486b-a419-74fdc8f92754
6e6616d3-9007-486b-a419-74fdc8f92754_32098_139897
innophos holdings, inc.
2014-01-15T14:28:33
45774N10
2014-04-15T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2014-Q1
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/c088151f-f706-4e21-bd03-834877c3af32/print/
c088151f-f706-4e21-bd03-834877c3af32
c088151f-f706-4e21-bd03-834877c3af32_32098_139897
innophos holdings, inc.
2014-04-15T18:48:48
45774N10
2014-07-21T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2014-Q2
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/50cfdf05-dea9-406e-8ce1-ed03811f2645/print/
50cfdf05-dea9-406e-8ce1-ed03811f2645
50cfdf05-dea9-406e-8ce1-ed03811f2645_32098_139897
innophos holdings, inc.
2014-07-21T22:18:52
45774N10
2014-10-14T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2014-Q3
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/cb5cc671-0e12-4ccb-bce4-b58112c33b02/print/
cb5cc671-0e12-4ccb-bce4-b58112c33b02
cb5cc671-0e12-4ccb-bce4-b58112c33b02_32098_139897
innophos holdings, inc.
2014-10-14T13:17:59
45774N10
2015-01-16T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2014-Q4
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/f359abce-1238-442a-b1d7-5337c5015e42/print/
f359abce-1238-442a-b1d7-5337c5015e42
f359abce-1238-442a-b1d7-5337c5015e42_32098_139897
innophos holdings, inc.
2015-01-16T20:05:27
45774N10
2015-03-01T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
service_provided
[ "United States foreign policy and trade relations with Morocco." ]
[ "FOR - Foreign Relations" ]
[ "24 - Commerce, Dept of (DOC)", "16 - Natl Security Council (NSC)", "1 - SENATE", "39 - State, Dept of (DOS)", "12 - White House Office" ]
2009-Q4
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
[ "STEVEN RICHARDS VALENTINE", "CRESENCIO S ARCOS", "KARISHMA SHAH PAGE" ]
[ 43785, 41123, 48804 ]
[ null, null, null ]
[ false, false, true ]
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/530a4a9d-bb73-4ac8-9ec1-8903ed07389c/print/
530a4a9d-bb73-4ac8-9ec1-8903ed07389c
530a4a9d-bb73-4ac8-9ec1-8903ed07389c_32098_139897
innophos holdings, inc.
null
45774N10
2015-03-01T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2016-Q4
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/299d79aa-b1dd-4566-b0ec-f052b922f792/print/
299d79aa-b1dd-4566-b0ec-f052b922f792
299d79aa-b1dd-4566-b0ec-f052b922f792_32098_139897
innophos holdings, inc.
null
45774N10
2015-04-13T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
10,000
lobbying_income
service_provided
[ "Environmental Protection Agency review of no-migration petition for well at Geismar, Louisiana plant." ]
[ "ENV - Environment/Superfund" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q1
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
[ "STEVEN RICHARDS VALENTINE", "CLIFF ROTHENSTEIN" ]
[ 43785, 53051 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/338b7be1-4913-45ee-9b3e-82ad8685fcf0/print/
338b7be1-4913-45ee-9b3e-82ad8685fcf0
338b7be1-4913-45ee-9b3e-82ad8685fcf0_32098_139897
innophos holdings, inc.
2015-04-13T14:30:36
45774N10
2015-07-20T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2015-Q2
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/3c6dbffc-fd97-419d-9f5b-34da7f890f87/print/
3c6dbffc-fd97-419d-9f5b-34da7f890f87
3c6dbffc-fd97-419d-9f5b-34da7f890f87_32098_139897
innophos holdings, inc.
2015-07-20T23:10:14
45774N10
2015-10-14T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2015-Q3
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/2e4cfd4d-66f0-4cd7-860f-d4d9cf82f374/print/
2e4cfd4d-66f0-4cd7-860f-d4d9cf82f374
2e4cfd4d-66f0-4cd7-860f-d4d9cf82f374_32098_139897
innophos holdings, inc.
2015-10-14T21:43:01
45774N10
2016-01-20T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
20,000
lobbying_income
service_provided
[ "EPA approval of deep well application." ]
[ "ENV - Environment/Superfund" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q4
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
[ "STEVEN RICHARDS VALENTINE", "CLIFF ROTHENSTEIN" ]
[ 43785, 53051 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/df72faf3-73b8-4cd8-b2ea-eda42b6d9829/print/
df72faf3-73b8-4cd8-b2ea-eda42b6d9829
df72faf3-73b8-4cd8-b2ea-eda42b6d9829_32098_139897
innophos holdings, inc.
2016-01-20T14:32:01
45774N10
2016-04-13T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
service_provided
[ "EPA approval of deep well application." ]
[ "ENV - Environment/Superfund" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q1
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
[ "STEVEN RICHARDS VALENTINE", "CLIFF ROTHENSTEIN" ]
[ 43785, 53051 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/b4e183eb-581d-4c01-a84b-1287d55d9e07/print/
b4e183eb-581d-4c01-a84b-1287d55d9e07
b4e183eb-581d-4c01-a84b-1287d55d9e07_32098_139897
innophos holdings, inc.
2016-04-13T20:47:49
45774N10
2016-07-20T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2016-Q2
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/f78350e9-751f-4236-8acd-467f63a7cd19/print/
f78350e9-751f-4236-8acd-467f63a7cd19
f78350e9-751f-4236-8acd-467f63a7cd19_32098_139897
innophos holdings, inc.
2016-07-20T18:37:17
45774N10
2016-10-18T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2016-Q3
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/72a2e276-0201-4388-8a85-29dde9e181cd/print/
72a2e276-0201-4388-8a85-29dde9e181cd
72a2e276-0201-4388-8a85-29dde9e181cd_32098_139897
innophos holdings, inc.
2016-10-18T19:25:00
45774N10
2017-04-20T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2017-Q1
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/865eab0a-9b2c-4a1b-8da5-cf5ecf77b54e/print/
865eab0a-9b2c-4a1b-8da5-cf5ecf77b54e
865eab0a-9b2c-4a1b-8da5-cf5ecf77b54e_32098_139897
innophos holdings, inc.
2017-04-20T13:27:39
45774N10
2017-07-14T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
retainer
[]
null
null
2017-Q2
2015-03-01
null
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/d5402d29-b51a-40b9-bcaf-c5b2f78d7a79/print/
d5402d29-b51a-40b9-bcaf-c5b2f78d7a79
d5402d29-b51a-40b9-bcaf-c5b2f78d7a79_32098_139897
innophos holdings, inc.
2017-07-14T17:07:13
45774N10
2017-10-12T00:00:00
innophos holdings, inc.
Producer of phosphate products for food, pharmaceutical and industrial industries.
5,000
lobbying_income
terminate_retainer
[]
null
null
2017-Q3
2015-03-01
2017-09-30
NJ
US
5,126
0
null
2024-01-24T11:38:27.060076-05:00
K&L GATES, LLP
1601 K Street, NW, Washington, DC, 20006, US
32,098
Law firm
CAROL MICHAELSEN
31,355
+1 202-661-3868
null
null
null
null
https://lda.senate.gov/api/v1/clients/139897/
https://lda.senate.gov/api/v1/registrants/32098/
https://lda.senate.gov/filings/public/filing/9edc6b82-b018-42cb-9a84-f5033fd9c114/print/
9edc6b82-b018-42cb-9a84-f5033fd9c114
9edc6b82-b018-42cb-9a84-f5033fd9c114_32098_139897
innophos holdings, inc.
2017-10-12T20:20:28
4641
2008-04-18T00:00:00
altech corporation
null
20,000
lobbying_income
modify_termination
[ "HR 1585, S 1547 House and Senate Defense Authorization and House and Senate Defense Appropriations. Funding for army range training upgrades." ]
[ "DEF - Defense" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q1
2007-08-02
2007-08-31
OK
US
4,531
0
0
2024-01-26T10:21:03.693944-05:00
STRATEGIC MARKETING INNOVATIONS
200 Massachusetts Avenue, Suite 510, Washington, DC, 20001, US
60,550
Federal relations firm
KENNETH WETZEL, JR.
35,365
+1 202-467-5459
[ "PATRICK PETERSON", "MICHAEL DEYOUNG" ]
[ 1117, 518 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/161089/
https://lda.senate.gov/api/v1/registrants/60550/
https://lda.senate.gov/filings/public/filing/d38c6207-8349-4463-b297-01190829b2f7/print/
d38c6207-8349-4463-b297-01190829b2f7
d38c6207-8349-4463-b297-01190829b2f7_60550_161089
altech corporation
2008-04-18T20:28:40
47214710
2012-03-01T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nPrescription drug abuse;\nSenate HELP Committee's Innovation Working Group;" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/eb106bae-65fd-4211-bc75-565bb773f1b8/print/
eb106bae-65fd-4211-bc75-565bb773f1b8
eb106bae-65fd-4211-bc75-565bb773f1b8_72111_165792
jazz pharmaceuticals, inc.
null
47214710
2012-04-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
5,000
lobbying_income
retainer
[]
null
null
2012-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
null
null
null
null
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/0f61d03e-2354-4b59-b528-1dfe8f8992aa/print/
0f61d03e-2354-4b59-b528-1dfe8f8992aa
0f61d03e-2354-4b59-b528-1dfe8f8992aa_72111_165792
jazz pharmaceuticals, inc.
2012-04-20T23:38:55
47214710
2012-07-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "S. 3187 Food and Drug Administration Safety and Innovation Act - Modification to REMS (risk evaluation and mitigation strategies) language;\nH.R. 5651 Food and Drug Administration Reform Act of 2012 - Modification to REMS (risk evaluation and mitigation strategies) language", "S. 3187 Food and Drug Administration Safety and Innovation Act - Modification to REMS (risk evaluation and mitigation strategies) language;\nH.R. 5651 Food and Drug Administration Reform Act of 2012 - Modification to REMS (risk evaluation and mitigation strategies) language" ]
[ "PHA - Pharmacy", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER", "AMY TEJRAL", "ELIZABETH MACDONALD BARNETT", "TRACY SPICER", "AMY TEJRAL" ]
[ 48260, 23462, 10838, 48260, 23462, 10838 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/3ecb3ea4-4f0d-45c6-b051-e2791c818abc/print/
3ecb3ea4-4f0d-45c6-b051-e2791c818abc
3ecb3ea4-4f0d-45c6-b051-e2791c818abc_72111_165792
jazz pharmaceuticals, inc.
2012-07-20T23:40:46
47214710
2012-10-21T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "S. 3187 Food and Drug Administration Safety and Innovation Act; \nH.R. 5651 Food and Drug Administration Reform Act of 2012" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER", "AMY TEJRAL" ]
[ 48260, 23462, 10838 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/0104bce9-d67a-4224-b7d2-53a54eddb8ee/print/
0104bce9-d67a-4224-b7d2-53a54eddb8ee
0104bce9-d67a-4224-b7d2-53a54eddb8ee_72111_165792
jazz pharmaceuticals, inc.
2012-10-21T23:16:27
47214710
2013-01-23T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of The Food and Drug Administration Safety and Innovation Act (PL 112-144); \ndrug safety issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER", "AMY TEJRAL" ]
[ 48260, 23462, 10838 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/229448f2-640e-4034-8ebb-95ae7dec62c0/print/
229448f2-640e-4034-8ebb-95ae7dec62c0
229448f2-640e-4034-8ebb-95ae7dec62c0_72111_165792
jazz pharmaceuticals, inc.
2013-01-23T00:53:44
47214710
2013-04-22T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of The Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER", "AMY TEJRAL" ]
[ 48260, 23462, 10838 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/4924c9a7-1b61-44d7-b68e-acd9098d58a1/print/
4924c9a7-1b61-44d7-b68e-acd9098d58a1
4924c9a7-1b61-44d7-b68e-acd9098d58a1_72111_165792
jazz pharmaceuticals, inc.
2013-04-22T23:26:47
47214710
2013-07-22T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER", "AMY TEJRAL" ]
[ 48260, 23462, 10838 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/2b624f04-3590-4a87-95a3-559f92808430/print/
2b624f04-3590-4a87-95a3-559f92808430
2b624f04-3590-4a87-95a3-559f92808430_72111_165792
jazz pharmaceuticals, inc.
2013-07-23T02:31:17
47214710
2013-10-21T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER", "AMY TEJRAL" ]
[ 48260, 23462, 10838 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/26e443e2-a691-40fa-b064-5c654d2e9796/print/
26e443e2-a691-40fa-b064-5c654d2e9796
26e443e2-a691-40fa-b064-5c654d2e9796_72111_165792
jazz pharmaceuticals, inc.
2013-10-22T00:13:17
47214710
2014-01-21T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER" ]
[ 48260, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/5881a585-ba2a-496a-87a0-b6e9e8bac478/print/
5881a585-ba2a-496a-87a0-b6e9e8bac478
5881a585-ba2a-496a-87a0-b6e9e8bac478_72111_165792
jazz pharmaceuticals, inc.
2014-01-21T19:33:33
47214710
2014-04-21T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues" ]
[ "HCR - Health Issues" ]
[ "11 - Executive Office of the President (EOP)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER" ]
[ 48260, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/400ff958-2e0b-43bf-b44f-e9f7ab8d3dd6/print/
400ff958-2e0b-43bf-b44f-e9f7ab8d3dd6
400ff958-2e0b-43bf-b44f-e9f7ab8d3dd6_72111_165792
jazz pharmaceuticals, inc.
2014-04-21T18:40:24
47214710
2014-07-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues;\nCampus sexual assault initiative" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER" ]
[ 48260, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/fb5f5884-751a-4d88-9872-742f5e4f8741/print/
fb5f5884-751a-4d88-9872-742f5e4f8741
fb5f5884-751a-4d88-9872-742f5e4f8741_72111_165792
jazz pharmaceuticals, inc.
2014-07-20T15:38:31
47214710
2014-10-18T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); \nDrug safety issues;\nCampus sexual assault initiative" ]
[ "HCR - Health Issues" ]
[ "1 - SENATE" ]
2014-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER" ]
[ 48260, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/99009db1-3207-4f4a-89f9-0ad591370b65/print/
99009db1-3207-4f4a-89f9-0ad591370b65
99009db1-3207-4f4a-89f9-0ad591370b65_72111_165792
jazz pharmaceuticals, inc.
2014-10-18T19:22:35
47214710
2015-01-21T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nCampus sexual assault initiative" ]
[ "HCR - Health Issues" ]
[ "1 - SENATE" ]
2014-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER" ]
[ 48260, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/543f4778-c550-4d8d-86c5-bc7b6a8ef5aa/print/
543f4778-c550-4d8d-86c5-bc7b6a8ef5aa
543f4778-c550-4d8d-86c5-bc7b6a8ef5aa_72111_165792
jazz pharmaceuticals, inc.
2015-01-21T01:39:39
47214710
2015-04-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\ncampus sexual assault initiative" ]
[ "HCR - Health Issues" ]
[ "1 - SENATE" ]
2015-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "ELIZABETH MACDONALD BARNETT", "TRACY SPICER" ]
[ 48260, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/18a60aa0-6caf-4458-b4b1-a7bf82522079/print/
18a60aa0-6caf-4458-b4b1-a7bf82522079
18a60aa0-6caf-4458-b4b1-a7bf82522079_72111_165792
jazz pharmaceuticals, inc.
2015-04-20T18:49:16
47214710
2015-07-17T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\ncampus sexual assault initiative;\nH.R. 6, 21st Century Cures", "H.R. 9, Innovation Act;\nS. 1137, PATENT Act" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER", "AMY TEJRAL" ]
[ 23462, 23462, 10838 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/1e1e62d0-5c88-43a9-87bc-d8fa1e7ba8e5/print/
1e1e62d0-5c88-43a9-87bc-d8fa1e7ba8e5
1e1e62d0-5c88-43a9-87bc-d8fa1e7ba8e5_72111_165792
jazz pharmaceuticals, inc.
2015-07-17T17:36:42
47214710
2015-10-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "H.R. 9, Innovation Act;\nS. 1137, PATENT Act", "implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\nH.R. 6, 21st Century Cures;\nprescription drug abuse" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues" ]
[ "1 - SENATE", "1 - SENATE" ]
2015-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "AMY TEJRAL", "TRACY SPICER" ]
[ 23462, 10838, 23462 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/b8d84a95-91f1-4e82-b1d7-f9a469931a7b/print/
b8d84a95-91f1-4e82-b1d7-f9a469931a7b
b8d84a95-91f1-4e82-b1d7-f9a469931a7b_72111_165792
jazz pharmaceuticals, inc.
2015-10-20T19:51:43
47214710
2016-01-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\ndrug safety issues;\nprescription drug abuse;\nSenate HELP Committee's Innovation Working Group;", "H.R. 9, Innovation Act;\nS. 1137, PATENT Act;\nS. 779, Fair Access to Science & Technology Research Act of 2015" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER", "AMY TEJRAL" ]
[ 23462, 23462, 10838 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/bf8e3bbc-97e7-4f53-84a2-f89fe67fdf68/print/
bf8e3bbc-97e7-4f53-84a2-f89fe67fdf68
bf8e3bbc-97e7-4f53-84a2-f89fe67fdf68_72111_165792
jazz pharmaceuticals, inc.
2016-01-20T15:41:01
47214710
2016-07-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES Act of 2016)", "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nPrescription drug abuse;" ]
[ "PHA - Pharmacy", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/b9538182-15e4-4abf-839c-6ae8f97c785b/print/
b9538182-15e4-4abf-839c-6ae8f97c785b
b9538182-15e4-4abf-839c-6ae8f97c785b_72111_165792
jazz pharmaceuticals, inc.
2016-07-19T18:17:27
47214710
2016-10-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144);\nDrug safety issues;\nPrescription drug abuse;\nH.R. 6, 21st Century Cures Act;\nH.R. 2841, FAST Generics Act", "S. 3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES Act of 2016)" ]
[ "HCR - Health Issues", "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/f0ee6021-0db7-4d42-b6e4-7af3d9d188af/print/
f0ee6021-0db7-4d42-b6e4-7af3d9d188af
f0ee6021-0db7-4d42-b6e4-7af3d9d188af_72111_165792
jazz pharmaceuticals, inc.
2016-10-20T17:40:26
47214710
2017-04-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (P.L. 112-144);\nDrug safety issues;\nPrescription drug abuse;\nReauthorization of FDA Prescription Drug User Fee Act (PDUFA) IV;\nH.R. 749, Lower Drug Costs Through Competition Act", "Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES Act of 2016) (formerly S. 3056);\nFAST Generics Act (formerly H.R. 2841)" ]
[ "HCR - Health Issues", "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/8012d738-0a74-4e88-ab39-5d1e6f095518/print/
8012d738-0a74-4e88-ab39-5d1e6f095518
8012d738-0a74-4e88-ab39-5d1e6f095518_72111_165792
jazz pharmaceuticals, inc.
2017-04-20T18:36:15
47214710
2017-07-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Implementation of Food and Drug Administration Safety and Innovation Act (P.L. 112-144);\nDrug safety issues;\nPrescription drug abuse;\nReauthorization of FDA Prescription Drug User Fee Act (PDUFA) VI;\nH.R. 749, Lower Drug Costs Through Competition Act", "S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017);\nH.R. 2051, FAST Generics Act" ]
[ "HCR - Health Issues", "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/b1f5e704-50cd-4740-901e-a3d798fb6de1/print/
b1f5e704-50cd-4740-901e-a3d798fb6de1
b1f5e704-50cd-4740-901e-a3d798fb6de1_72111_165792
jazz pharmaceuticals, inc.
2017-07-19T15:01:06
47214710
2017-10-17T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017);\nH.R. 2051, FAST Generics Act", "Drug safety issues;\nPrescription drug abuse;\nReauthorization of FDA Prescription Drug User Fee Act (PDUFA) VI;\nH.R. 749, Lower Drug Costs Through Competition Act;\nCHIP reauthorization;\nMedicare extenders negotiations" ]
[ "PHA - Pharmacy", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/24dfea5f-8918-464e-910f-2b1d83b8bdab/print/
24dfea5f-8918-464e-910f-2b1d83b8bdab
24dfea5f-8918-464e-910f-2b1d83b8bdab_72111_165792
jazz pharmaceuticals, inc.
2017-10-17T16:09:22
47214710
2018-01-22T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Drug safety issues;\nPrescription drug abuse;\nH.R. 749, Lower Drug Costs Through Competition Act;\nCHIP reauthorization;\nMedicare extenders negotiations", "H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017);\nH.R. 2051, FAST Generics Act" ]
[ "HCR - Health Issues", "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/e1bcc62f-e995-48db-ad05-8f2e068e0623/print/
e1bcc62f-e995-48db-ad05-8f2e068e0623
e1bcc62f-e995-48db-ad05-8f2e068e0623_72111_165792
jazz pharmaceuticals, inc.
2018-01-22T22:05:08
47214710
2018-04-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "PL 114-255, 21st Century Cures Act, implementation\nH.R. 4784, Lower Drug Costs Through Competition Act\nS. 974/H.R. 2212, CREATES Act of 2015\nH.R. 2051, FAST Generics\nDrug safety issues\nPrescription drug abuse \nH.R. 1892/PL 115-123, Bipartisan Budget Act of 2018\nH.R. 1625/PL 115-141, Consolidated Appropriations Act of 2018" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/04c848a7-c150-4d7f-9741-4fe45c38ca42/print/
04c848a7-c150-4d7f-9741-4fe45c38ca42
04c848a7-c150-4d7f-9741-4fe45c38ca42_72111_165792
jazz pharmaceuticals, inc.
2018-04-20T01:18:24
47214710
2018-07-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "PL 114-255, 21st Century Cures Act, implementation; \n\nH.R. 4784, Lower Drug Costs Through Competition Act; \n\nS. 974/H.R. 2212, CREATES Act of 2015; \n\nH.R. 2051, FAST Generics; \n\nDrug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); \n\nS. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);\n\nS. 2680, Opioid Crisis Response Act of 2018" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/b3f52912-26f2-40b6-9108-189663a1733b/print/
b3f52912-26f2-40b6-9108-189663a1733b
b3f52912-26f2-40b6-9108-189663a1733b_72111_165792
jazz pharmaceuticals, inc.
2018-07-19T17:50:44
47214710
2018-10-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "PL 114-255, 21st Century Cures Act, implementation; \n\nH.R. 4784, Lower Drug Costs Through Competition Act; \n\nS. 974/H.R. 2212, CREATES Act of 2015; \n\nH.R. 2051, FAST Generics; \n\nDrug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); \n\nS. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);\n\nS. 2680, Opioid Crisis Response Act of 2018" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/ce91e45c-fc28-4319-8966-07952549b4df/print/
ce91e45c-fc28-4319-8966-07952549b4df
ce91e45c-fc28-4319-8966-07952549b4df_72111_165792
jazz pharmaceuticals, inc.
2018-10-19T14:48:55
47214710
2019-01-21T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "PL 114-255, 21st Century Cures Act, implementation; \n\nH.R. 4784, Lower Drug Costs Through Competition Act; \n\nS. 974/H.R. 2212, CREATES Act of 2015; \n\nH.R. 2051, FAST Generics; \n\nDrug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); \n\nS. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);\n\nS. 2680, Opioid Crisis Response Act of 2018" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/858270fc-aca0-450a-8c23-9f167a5cfbdf/print/
858270fc-aca0-450a-8c23-9f167a5cfbdf
858270fc-aca0-450a-8c23-9f167a5cfbdf_72111_165792
jazz pharmaceuticals, inc.
2019-01-21T19:43:27
47214710
2019-04-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
60,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nIssues related to opioids policies and offsets;\n\nH.R. 965/ S. 340, CREATES Act of 2019" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/c25621d1-6324-4291-82f5-3f0d8dafc924/print/
c25621d1-6324-4291-82f5-3f0d8dafc924
c25621d1-6324-4291-82f5-3f0d8dafc924_72111_165792
jazz pharmaceuticals, inc.
2019-04-19T16:52:17
47214710
2019-07-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
0
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/41600c3f-3ada-40e7-acbe-1ac76acc5e08/print/
41600c3f-3ada-40e7-acbe-1ac76acc5e08
41600c3f-3ada-40e7-acbe-1ac76acc5e08_72111_165792
jazz pharmaceuticals, inc.
2019-07-19T22:15:35
47214710
2019-10-17T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/15220ed4-fa34-4b57-8c48-946d0ce6c060/print/
15220ed4-fa34-4b57-8c48-946d0ce6c060
15220ed4-fa34-4b57-8c48-946d0ce6c060_72111_165792
jazz pharmaceuticals, inc.
2019-10-17T23:28:44
47214710
2019-10-17T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
modify_service
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/5f116c4c-8762-4dc6-9d38-5548abd9fae0/print/
5f116c4c-8762-4dc6-9d38-5548abd9fae0
5f116c4c-8762-4dc6-9d38-5548abd9fae0_72111_165792
jazz pharmaceuticals, inc.
2019-10-17T23:31:46
47214710
2020-01-18T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nH.R. 965/ S. 340, CREATES Act of 2019; \n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 1865, Consolidated Domestic and International Assistance Bill;\n\nH.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/28c140ad-08f0-42ef-87fd-6fb1fc4b3a09/print/
28c140ad-08f0-42ef-87fd-6fb1fc4b3a09
28c140ad-08f0-42ef-87fd-6fb1fc4b3a09_72111_165792
jazz pharmaceuticals, inc.
2020-01-18T15:46:45
47214710
2020-04-17T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019;\n\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act;\n\nH.R. 748 (Public Law 116-136), CARES Act" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/9654df45-a70f-4945-bc6a-cbef89b3bd92/print/
9654df45-a70f-4945-bc6a-cbef89b3bd92
9654df45-a70f-4945-bc6a-cbef89b3bd92_72111_165792
jazz pharmaceuticals, inc.
2020-04-17T18:21:22
47214710
2020-07-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019;\n\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act;\n\nPublic Law 116-136, CARES Act;\n\nH.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA)" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/5ab8f169-a2b6-4399-b1af-f7d5cedf380e/print/
5ab8f169-a2b6-4399-b1af-f7d5cedf380e
5ab8f169-a2b6-4399-b1af-f7d5cedf380e_72111_165792
jazz pharmaceuticals, inc.
2020-07-20T22:20:20
47214710
2020-10-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019;\n\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act;\n\nPublic Law 116-136, CARES Act;\n\nH.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA);\n\nIssues related to Priority Review Voucher extension;\n\nH.R. 6800, The Heroes Act; \n\nH.R. 925, The Heroes Act" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/9fe095a6-2b78-4ecc-ba04-8851b5b29108/print/
9fe095a6-2b78-4ecc-ba04-8851b5b29108
9fe095a6-2b78-4ecc-ba04-8851b5b29108_72111_165792
jazz pharmaceuticals, inc.
2020-10-20T21:38:33
47214710
2021-01-21T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nH.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act;\n\nS. 1895, Lower Health Care Costs Act;\n\nS. 1416, Affordable Prescriptions for Patients Act of 2019;\n\nH.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019;\n\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act;\n\nPublic Law 116-136, CARES Act;\n\nH.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA);\n\nIssues related to Priority Review Voucher extension;\n\nH.R. 6800, The Heroes Act; \n\nH.R. 925, The Heroes Act;\n\nH.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/5c2ecf4e-4d34-4510-9729-a8d0a6f21fe7/print/
5c2ecf4e-4d34-4510-9729-a8d0a6f21fe7
5c2ecf4e-4d34-4510-9729-a8d0a6f21fe7_72111_165792
jazz pharmaceuticals, inc.
2021-01-21T18:24:23
47214710
2021-04-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nPrescription drug abuse; \n\nMonitor drug pricing legislation; \n\nContinue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress ; \n\nContinue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; \n\nContinue monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; \n\nContinue monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress\n\nContinue monitoring Consolidated Appropriations Act, 2021 (PL 116-260);\n\nH.R. 1319, American Rescue Plan Act of 2021 (PL 117-2)" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/d0d8ad37-bec6-402e-a2a4-0ce810a713d5/print/
d0d8ad37-bec6-402e-a2a4-0ce810a713d5
d0d8ad37-bec6-402e-a2a4-0ce810a713d5_72111_165792
jazz pharmaceuticals, inc.
2021-04-20T16:16:23
47214710
2021-07-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nMonitor drug pricing legislation; \n\nContinue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress; \n\nContinue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; \n\nContinue monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; \n\nContinue monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress;\n\nSenate Finance Committee Prescription Drug Pricing Reform Principles;\n\nImplementation of American Rescue Plan Act of 2021 (PL 117-2)", "Issues related to patent thicketing" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/23ff0bff-bfa2-45db-b628-c08bbf10e694/print/
23ff0bff-bfa2-45db-b628-c08bbf10e694
23ff0bff-bfa2-45db-b628-c08bbf10e694_72111_165792
jazz pharmaceuticals, inc.
2021-07-20T20:52:54
47214710
2021-07-20T00:00:00
jazz pharmaceuticals, inc.
null
160,000
a
service_provided
[ "Drug pricing" ]
[ "PHA - Pharmacy" ]
[ "1 - SENATE" ]
2021-Q2
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "VIRGINIA MCMILLIN (Special Assistant to the President (9/2018-12/2020); Health Policy Advisor, Senate Committee on HELP (1/2018-9/2019); Staff, Senate Committee on HELP (5/2012-1/2018))" ]
[ 100657 ]
[ "Special Assistant to the President (9/2018-12/2020); Health Policy Advisor, Senate Committee on HELP (1/2018-9/2019); Staff, Senate Committee on HELP (5/2012-1/2018)" ]
[ true ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/8dea1b82-f1d1-45ba-964d-a94c6fc6744e/print/
8dea1b82-f1d1-45ba-964d-a94c6fc6744e
8dea1b82-f1d1-45ba-964d-a94c6fc6744e_401106071_210180
jazz pharmaceuticals, inc.
2021-07-20T22:34:46
47214710
2021-10-20T00:00:00
jazz pharmaceuticals, inc.
null
160,000
a
service_provided
[ "HR 3 - Drug pricing" ]
[ "PHA - Pharmacy" ]
[ "1 - SENATE" ]
2021-Q3
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "VIRGINIA MCMILLIN" ]
[ 100657 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/aa952e75-7c49-401b-bb50-40203d6847bd/print/
aa952e75-7c49-401b-bb50-40203d6847bd
aa952e75-7c49-401b-bb50-40203d6847bd_401106071_210180
jazz pharmaceuticals, inc.
2021-10-20T16:53:00
47214710
2021-10-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; \n\nMonitor drug pricing legislation; \n\nContinue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress; \n\nContinue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; \n\nContinue monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; \n\nContinue monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress;\n\nSenate Finance Committee Prescription Drug Pricing Reform Principles;\n\nImplementation of American Rescue Plan Act of 2021 (PL 117-2)\n\nH.R. 5376, Build Back Better Act; \n\nMonitor Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; \n\nProposed repeal of the CMS Rule on Most Favored Nation Model;\n\nDelay of the Rebate Rule", "S. 1435, Affordable Prescriptions for Patients Act of 2021" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/b30cb904-32e2-4df1-8e1e-a5b059ddd248/print/
b30cb904-32e2-4df1-8e1e-a5b059ddd248
b30cb904-32e2-4df1-8e1e-a5b059ddd248_72111_165792
jazz pharmaceuticals, inc.
2021-10-20T22:05:03
47214710
2022-01-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues;\n\nMonitor drug pricing legislation;\n\nContinued monitoring drug pricing legislation, including S. 1435, Affordable Prescriptions for Patients Act; H.R. 2873, Affordable Prescriptions for Patients Through Promoting Competition Act; H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;\n\nSenate Finance Committee Prescription Drug Pricing Reform Principles;\n\nImplementation of American Rescue Plan Act of2021 (PL 117-2);\n\nH.R. 5376, Build Back Better Act; \n\nMonitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; \n\nProposed repeal of the CMS Rule on Most Favored Nation Model; \n\nDelay of the Rebate Rule; \n\nPL 117-58 - Infrastructure Investment and Jobs Act (BIF) - issues related to rebate rule delay, repurposed Provider Relief Funds, Medicare savings from single source vial size drug policy and extension of mandatory sequester); \n\nPL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically: 6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo", "S. 1435, Affordable Prescriptions for Patients Act of 2021" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/216acf8f-b791-49a1-8d5c-e29a6eb7052d/print/
216acf8f-b791-49a1-8d5c-e29a6eb7052d
216acf8f-b791-49a1-8d5c-e29a6eb7052d_72111_165792
jazz pharmaceuticals, inc.
2022-01-19T22:40:42
47214710
2022-01-20T00:00:00
jazz pharmaceuticals, inc.
null
90,000
direct_lobbying_expense
service_provided
[ "HR 3 - Drug pricing Reform" ]
[ "PHA - Pharmacy" ]
[ "1 - SENATE" ]
2021-Q4
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "VIRGINIA MCMILLIN" ]
[ 100657 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/6ed350d1-5c6b-4721-8729-f1eab5c0eb64/print/
6ed350d1-5c6b-4721-8729-f1eab5c0eb64
6ed350d1-5c6b-4721-8729-f1eab5c0eb64_401106071_210180
jazz pharmaceuticals, inc.
2022-01-20T14:38:50
47214710
2022-04-20T00:00:00
jazz pharmaceuticals, inc.
null
460,000
direct_lobbying_expense
modify_service
[ "H.R.1996 - SAFE Banking Act of 2021 Cannabis Administration & Opportunity Act Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement. FDA regulation of cannabis-derived products" ]
[ "PHA - Pharmacy" ]
[ "135 - Food & Drug Administration (FDA)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2022-Q1
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "VIRGINIA MCMILLIN", "KARAS GROSS (FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19); House Judiciary Committee - Deputy Parliamentarian (2008-11); House of Representatives - Sr. Legislative Assistant (2004-08))" ]
[ 100657, 139471 ]
[ null, "FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19); House Judiciary Committee - Deputy Parliamentarian (2008-11); House of Representatives - Sr. Legislative Assistant (2004-08)" ]
[ false, true ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/4a90d4d2-7e5c-41ad-9c95-ff695f25e5bb/print/
4a90d4d2-7e5c-41ad-9c95-ff695f25e5bb
4a90d4d2-7e5c-41ad-9c95-ff695f25e5bb_401106071_210180
jazz pharmaceuticals, inc.
2022-04-20T16:50:10
47214710
2022-04-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; Monitor drug pricing legislation; H.R. 5376, Build Back Better Act; Monitor Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Issues related to reauthorization of FDA user fee bills including accelerated approval; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Consolidated Appropriations Act, 2022 (PL 117-103)", "S. 1435, Affordable Prescriptions for Patients Act of 2021" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
null
2022-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/480498a1-3a3a-4d61-b07f-a39ea9c98f27/print/
480498a1-3a3a-4d61-b07f-a39ea9c98f27
480498a1-3a3a-4d61-b07f-a39ea9c98f27_72111_165792
jazz pharmaceuticals, inc.
2022-04-20T22:57:29
47214710
2022-07-20T00:00:00
jazz pharmaceuticals, inc.
null
530,000
direct_lobbying_expense
service_provided
[ "H.R.1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement" ]
[ "PHA - Pharmacy" ]
[ "135 - Food & Drug Administration (FDA)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2022-Q2
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "VIRGINIA MCMILLIN", "KARAS GROSS" ]
[ 100657, 139471 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/5bda1d50-dc02-40d2-a619-8d514436a55d/print/
5bda1d50-dc02-40d2-a619-8d514436a55d
5bda1d50-dc02-40d2-a619-8d514436a55d_401106071_210180
jazz pharmaceuticals, inc.
2022-07-20T15:57:49
47214710
2022-07-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; Monitor drug pricing legislation; H.R. 5376, Build Back Better Act; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Issues related to FDA user fee reauthorization bills ( H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval, reimportation, and orphan drugs; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Consolidated Appropriations Act, 2022 (PL 117-103)", "S. 1435, Affordable Prescriptions for Patients Act of 2021" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "1 - SENATE" ]
2022-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/96e5ffb9-24c5-4bdf-a453-6781e7e282b5/print/
96e5ffb9-24c5-4bdf-a453-6781e7e282b5
96e5ffb9-24c5-4bdf-a453-6781e7e282b5_72111_165792
jazz pharmaceuticals, inc.
2022-07-20T19:17:52
47214710
2022-10-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety issues; Monitor drug pricing legislation; Issues related to FDA user fee reauthorization bills ( H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval, reimportation, and orphan drugs; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Issues related to H.R. 5376, Inflation Reduction Act of 2022 (now PL 117-169) and implementation; Issues related to the Continuing Resolution, H.R. 6833", "S. 1435, Affordable Prescriptions for Patients Act of 2021" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "1 - SENATE" ]
2022-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/4b6922dc-d588-44fd-bf53-5ed2afb7c394/print/
4b6922dc-d588-44fd-bf53-5ed2afb7c394
4b6922dc-d588-44fd-bf53-5ed2afb7c394_72111_165792
jazz pharmaceuticals, inc.
2022-10-20T14:29:26
47214710
2022-10-20T00:00:00
jazz pharmaceuticals, inc.
null
490,000
direct_lobbying_expense
service_provided
[ "H.R. 1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement FDA regulation of cannabis derived products" ]
[ "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2022-Q3
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "KARAS GROSS", "VIRGINIA MCMILLIN" ]
[ 139471, 100657 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/93b47f37-b7cc-4a3a-9643-cf1fd6bd8e89/print/
93b47f37-b7cc-4a3a-9643-cf1fd6bd8e89
93b47f37-b7cc-4a3a-9643-cf1fd6bd8e89_401106071_210180
jazz pharmaceuticals, inc.
2022-10-20T21:27:18
47214710
2023-01-19T00:00:00
jazz pharmaceuticals, inc.
null
640,000
direct_lobbying_expense
service_provided
[ "Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement" ]
[ "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2022-Q4
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "KARAS GROSS" ]
[ 139471 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/c29b07f6-5e4b-4b78-b472-195d2453835a/print/
c29b07f6-5e4b-4b78-b472-195d2453835a
c29b07f6-5e4b-4b78-b472-195d2453835a_401106071_210180
jazz pharmaceuticals, inc.
2023-01-19T22:45:03
47214710
2023-01-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Drug safety, prescription drug abuse, drug pricing; Inflation Reduction Act of 2022 (PL 117-169); S. 4348, FDA Safety and Landmark Advancements Act; H.R. 7667, Food and Drug Amendments of 2022 H.R. 2617, Consolidated Appropriations Act, 2023" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2022-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER" ]
[ 23462 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/5e8bd077-4371-40d5-9a55-e056f2fbe564/print/
5e8bd077-4371-40d5-9a55-e056f2fbe564
5e8bd077-4371-40d5-9a55-e056f2fbe564_72111_165792
jazz pharmaceuticals, inc.
2023-01-20T19:15:13
47214710
2023-04-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)", "Drug safety, prescription drug abuse, drug pricing" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2023-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/4371057e-a36d-4ba4-9283-90d5ac171ede/print/
4371057e-a36d-4ba4-9283-90d5ac171ede
4371057e-a36d-4ba4-9283-90d5ac171ede_72111_165792
jazz pharmaceuticals, inc.
2023-04-20T18:19:20
47214710
2023-04-20T00:00:00
jazz pharmaceuticals, inc.
null
630,000
direct_lobbying_expense
service_provided
[ "Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations and FDA regulation and enforcement Drug safety, prescription drug abuse and drug pricing" ]
[ "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2023-Q1
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "KARAS GROSS", "VIRGINIA MCMILLIN" ]
[ 139471, 100657 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/416f2910-eb22-44a2-9205-3ed6d712c8ce/print/
416f2910-eb22-44a2-9205-3ed6d712c8ce
416f2910-eb22-44a2-9205-3ed6d712c8ce_401106071_210180
jazz pharmaceuticals, inc.
2023-04-20T20:52:10
47214710
2023-07-19T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)", "Drug safety, prescription drug abuse, value of prescription drugs" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2023-Q2
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/9f81a6fd-87c6-43e2-adff-d2339e1b962b/print/
9f81a6fd-87c6-43e2-adff-d2339e1b962b
9f81a6fd-87c6-43e2-adff-d2339e1b962b_72111_165792
jazz pharmaceuticals, inc.
2023-07-19T21:36:27
47214710
2023-07-20T00:00:00
jazz pharmaceuticals, inc.
null
640,000
direct_lobbying_expense
service_provided
[ "Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations and FDA regulation/enforcement Drug safety, prescription drug abuse and drug pricing SAFE Banking Act 2023" ]
[ "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2023-Q2
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "MARK BOLTON", "VIRGINIA MCMILLIN", "KARAS GROSS" ]
[ 143458, 100657, 139471 ]
[ null, null, null ]
[ true, false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/a9db2268-51a7-4c88-bf78-9cbe80a129d2/print/
a9db2268-51a7-4c88-bf78-9cbe80a129d2
a9db2268-51a7-4c88-bf78-9cbe80a129d2_401106071_210180
jazz pharmaceuticals, inc.
2023-07-20T19:47:37
47214710
2023-10-19T00:00:00
jazz pharmaceuticals, inc.
null
640,000
direct_lobbying_expense
service_provided
[ "Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023" ]
[ "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2023-Q3
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "MARK BOLTON", "VIRGINIA MCMILLIN", "KARAS GROSS" ]
[ 143458, 100657, 139471 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/f5367ec9-a2f4-4fff-8ffa-c2080a303dc6/print/
f5367ec9-a2f4-4fff-8ffa-c2080a303dc6
f5367ec9-a2f4-4fff-8ffa-c2080a303dc6_401106071_210180
jazz pharmaceuticals, inc.
2023-10-19T22:39:16
47214710
2023-10-20T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)", "Drug safety, prescription drug abuse, value of prescription drugs; Issues related to FDA oversight of CBD" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2023-Q3
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/3a0d24c3-143e-49a4-8054-c4af0f0b96d5/print/
3a0d24c3-143e-49a4-8054-c4af0f0b96d5
3a0d24c3-143e-49a4-8054-c4af0f0b96d5_72111_165792
jazz pharmaceuticals, inc.
2023-10-20T14:27:08
47214710
2024-01-22T00:00:00
jazz pharmaceuticals, inc.
null
0
direct_lobbying_expense
service_provided
[ "Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023" ]
[ "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "71 - Natl Credit Union Administration (NCUA)", "1 - SENATE" ]
2023-Q4
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "MARK BOLTON", "VIRGINIA MCMILLIN", "KARAS GROSS" ]
[ 143458, 100657, 139471 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/49ee4e2c-1f00-45e0-9492-180bf8d20a0b/print/
49ee4e2c-1f00-45e0-9492-180bf8d20a0b
49ee4e2c-1f00-45e0-9492-180bf8d20a0b_401106071_210180
jazz pharmaceuticals, inc.
2024-01-22T19:54:37
47214710
2024-01-22T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
80,000
lobbying_income
service_provided
[ "Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)", "Drug safety, prescription drug abuse, value of prescription drugs; Issues related to FDA oversight of CBD; Expiring healthcare extenders" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "1 - SENATE" ]
2023-Q4
2012-03-01
null
CA
US
1,004,164
0
0
2024-01-30T15:01:29.953318-05:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/23dab646-731d-4fd6-9ba0-38392540412f/print/
23dab646-731d-4fd6-9ba0-38392540412f
23dab646-731d-4fd6-9ba0-38392540412f_72111_165792
jazz pharmaceuticals, inc.
2024-01-22T21:45:10
47214710
2024-04-19T00:00:00
jazz pharmaceuticals, inc.
null
690,000
direct_lobbying_expense
modify_service
[ "Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023" ]
[ "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "71 - Natl Credit Union Administration (NCUA)", "1 - SENATE" ]
2023-Q4
2022-01-01
null
CA
US
12
0
1
2024-01-30T10:20:24.911943-05:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "MARK BOLTON", "VIRGINIA MCMILLIN", "KARAS GROSS" ]
[ 143458, 100657, 139471 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/7397d2a5-1f45-48bb-b05f-fa33f473a731/print/
7397d2a5-1f45-48bb-b05f-fa33f473a731
7397d2a5-1f45-48bb-b05f-fa33f473a731_401106071_210180
jazz pharmaceuticals, inc.
2024-04-19T23:21:48
47214710
2024-04-19T00:00:00
jazz pharmaceuticals, inc.
null
0
direct_lobbying_expense
service_provided
[ "Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies" ]
[ "PHA - Pharmacy" ]
[ "135 - Food & Drug Administration (FDA)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2024-Q1
2022-01-01
null
CA
US
12
0
1
2024-07-26T16:55:00.714723-04:00
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
401,106,071
Pharmaceuticals
JENNIE SKELTON
401,106,071
+1 415-903-2800
[ "MARK BOLTON", "VIRGINIA MCMILLIN", "KARAS GROSS" ]
[ 143458, 100657, 139471 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/210180/
https://lda.senate.gov/api/v1/registrants/401106071/
https://lda.senate.gov/filings/public/filing/9ed4bee6-bf9b-49cc-9119-783f7724e0e6/print/
9ed4bee6-bf9b-49cc-9119-783f7724e0e6
9ed4bee6-bf9b-49cc-9119-783f7724e0e6_401106071_210180
jazz pharmaceuticals, inc.
2024-04-19T22:22:04
47214710
2024-04-22T00:00:00
jazz pharmaceuticals, inc.
Specialty pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to biosecurity", "Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)", "Drug safety, prescription drug abuse, value of prescription drugs; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)" ]
[ "DEF - Defense", "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2024-Q1
2012-03-01
null
CA
US
1,004,164
0
0
2024-07-30T19:14:36.870757-04:00
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
72,111
Government representation
AMY TEJRAL
35,940
+1 202-347-9848
[ "TRACY SPICER", "TRACY SPICER", "TRACY SPICER" ]
[ 23462, 23462, 23462 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/165792/
https://lda.senate.gov/api/v1/registrants/72111/
https://lda.senate.gov/filings/public/filing/cd716564-542e-4fd0-b36b-9162ee2b0e37/print/
cd716564-542e-4fd0-b36b-9162ee2b0e37
cd716564-542e-4fd0-b36b-9162ee2b0e37_72111_165792
jazz pharmaceuticals, inc.
2024-04-22T20:33:36
4755
2007-08-07T00:00:00
medical device manufacturers association
null
20,000
lobbying_income
terminate
[ "H.R.3590, Patient Protection and Affordable Care Act, S.301, Physician Payments Sunshine Act of 2009; H.R.3962, America's Affordable Health Choices Act of 2009; S.1679, Affordable Health Choices Act; America's Healthy Future Act of 2009; Issues related to healthcare reform legislation; Issues related to group purchasing organizations' Medicare Safe Harbor." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q4
2007-08-07
2009-12-31
DC
US
3,693
0
0
2024-04-02T09:42:37.694409-04:00
OGR
1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US
48,827
lobbying firm
RAWSON WARDEN
34,528
+1 202-729-4200
[ "ANDREW ROSENBERG" ]
[ 37206 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/155797/
https://lda.senate.gov/api/v1/registrants/48827/
https://lda.senate.gov/filings/public/filing/ca0d92ce-02aa-4313-bbaa-55562a68892f/print/
ca0d92ce-02aa-4313-bbaa-55562a68892f
ca0d92ce-02aa-4313-bbaa-55562a68892f_48827_155797
medical device manufacturers association
null
4755
2007-08-08T00:00:00
medical device manufacturers association
null
15,000
lobbying_income
service_provided
[ "H.R. 3200--American's Affordable Health Choices Act\nS.1796--America's Healthy Future Act of 2009\nMedical Device Excise Tax" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q4
2007-08-08
null
DC
US
36
0
null
2024-04-05T13:54:32.459249-04:00
WALTER CONSULTING
7111 Capitol View Drive, McLean, VA, 22101, US
301,697
Federal health care advocacy
MRS. SARAH WALTER
37,801
+1 202-288-8190
[ "SARAH WALTER (Former Legislative Director, Sen. John Breaux)" ]
[ 33110 ]
[ "Former Legislative Director, Sen. John Breaux" ]
[ false ]
https://lda.senate.gov/api/v1/clients/180707/
https://lda.senate.gov/api/v1/registrants/301697/
https://lda.senate.gov/filings/public/filing/4bdb24cf-f186-41e4-a72f-ef5f61d2d084/print/
4bdb24cf-f186-41e4-a72f-ef5f61d2d084
4bdb24cf-f186-41e4-a72f-ef5f61d2d084_301697_180707
medical device manufacturers association
null
4755
2007-08-14T00:00:00
medical device manufacturers association
null
5,000
lobbying_income
retainer
[]
null
null
2009-Q4
2007-08-14
null
DC
US
1,038
0
null
2022-04-06T16:04:30.396745-04:00
LATHAM & WATKINS LLP
555 11th Street, NW, Suite 1000, Washington, DC, 20004, US
22,201
law firm
EMILY GIBSON
30,855
+1 213-892-3210
null
null
null
null
https://lda.senate.gov/api/v1/clients/129079/
https://lda.senate.gov/api/v1/registrants/22201/
https://lda.senate.gov/filings/public/filing/51df5678-a653-4371-96e7-028f41798910/print/
51df5678-a653-4371-96e7-028f41798910
51df5678-a653-4371-96e7-028f41798910_22201_129079
medical device manufacturers association
null
4755
2007-08-14T00:00:00
medical device manufacturers association
null
5,000
lobbying_income
retainer
[]
null
null
2011-Q4
2007-08-14
null
DC
US
1,038
0
null
2022-04-06T16:04:30.396745-04:00
LATHAM & WATKINS LLP
555 11th Street, NW, Suite 1000, Washington, DC, 20004, US
22,201
law firm
EMILY GIBSON
30,855
+1 213-892-3210
null
null
null
null
https://lda.senate.gov/api/v1/clients/129079/
https://lda.senate.gov/api/v1/registrants/22201/
https://lda.senate.gov/filings/public/filing/06dc6ebd-821c-431d-b738-9bc19376d5c9/print/
06dc6ebd-821c-431d-b738-9bc19376d5c9
06dc6ebd-821c-431d-b738-9bc19376d5c9_22201_129079
medical device manufacturers association
null
4755
2007-08-14T00:00:00
medical device manufacturers association
null
5,000
lobbying_income
retainer
[]
null
null
2016-Q4
2007-08-14
null
DC
US
1,038
0
null
2022-04-06T16:04:30.396745-04:00
LATHAM & WATKINS LLP
555 11th Street, NW, Suite 1000, Washington, DC, 20004, US
22,201
law firm
EMILY GIBSON
30,855
+1 213-892-3210
null
null
null
null
https://lda.senate.gov/api/v1/clients/129079/
https://lda.senate.gov/api/v1/registrants/22201/
https://lda.senate.gov/filings/public/filing/9eabd244-f973-4bcf-ac72-ca4d1e4ea17f/print/
9eabd244-f973-4bcf-ac72-ca4d1e4ea17f
9eabd244-f973-4bcf-ac72-ca4d1e4ea17f_22201_129079
medical device manufacturers association
null
4755
2008-04-15T00:00:00
medical device manufacturers association
null
15,000
lobbying_income
service_provided
[ "S.2029--Physician Payments Sunshine Act of 2007\nEnsuring patient access to innovative medical technologies" ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q1
2007-08-08
null
DC
US
36
0
null
2024-04-05T13:54:32.459249-04:00
WALTER CONSULTING
7111 Capitol View Drive, McLean, VA, 22101, US
301,697
Federal health care advocacy
MRS. SARAH WALTER
37,801
+1 202-288-8190
[ "SARAH WALTER" ]
[ 33110 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/180707/
https://lda.senate.gov/api/v1/registrants/301697/
https://lda.senate.gov/filings/public/filing/71312cbd-6016-4f5f-8c36-3e6fbd532690/print/
71312cbd-6016-4f5f-8c36-3e6fbd532690
71312cbd-6016-4f5f-8c36-3e6fbd532690_301697_180707
medical device manufacturers association
2008-04-15T18:55:23
4755
2008-04-16T00:00:00
medical device manufacturers association
null
5,000
lobbying_income
service_provided
[ "Oversight of the Food and Drug Administration" ]
[ "MED - Medical/Disease Research/Clinical Labs" ]
[ "135 - Food & Drug Administration (FDA)" ]
2008-Q1
2007-08-14
null
DC
US
1,038
0
null
2022-04-06T16:04:30.396745-04:00
LATHAM & WATKINS LLP
555 11th Street, NW, Suite 1000, Washington, DC, 20004, US
22,201
law firm
EMILY GIBSON
30,855
+1 213-892-3210
[ "JOHN MANTHEI" ]
[ 4223 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/129079/
https://lda.senate.gov/api/v1/registrants/22201/
https://lda.senate.gov/filings/public/filing/9ba0e580-fc09-4442-aee6-3277ae11b213/print/
9ba0e580-fc09-4442-aee6-3277ae11b213
9ba0e580-fc09-4442-aee6-3277ae11b213_22201_129079
medical device manufacturers association
2008-04-16T18:54:45
4755
2008-04-17T00:00:00
medical device manufacturers association
null
20,000
lobbying_income
service_provided
[ "S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.\nIssues related to group purchasing organizations' Medicare Safe Harbor." ]
[ "MMM - Medicare/Medicaid" ]
null
2008-Q1
2007-08-07
null
DC
US
3,693
0
0
2024-04-02T09:42:37.694409-04:00
OGR
1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US
48,827
lobbying firm
RAWSON WARDEN
34,528
+1 202-729-4200
[ "ANDREW ROSENBERG", "JULIE DAMMANN (Chief of Staff, Senator Christopher S. Bond)", "WAYNE BERMAN" ]
[ 37206, 3791, 20506 ]
[ null, "Chief of Staff, Senator Christopher S. Bond", null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/155797/
https://lda.senate.gov/api/v1/registrants/48827/
https://lda.senate.gov/filings/public/filing/985372d9-569d-42e9-878c-fe713508515b/print/
985372d9-569d-42e9-878c-fe713508515b
985372d9-569d-42e9-878c-fe713508515b_48827_155797
medical device manufacturers association
2008-04-17T14:25:03
4755
2008-04-19T00:00:00
medical device manufacturers association
null
5,000
lobbying_income
terminate_retainer
[]
null
null
2008-Q1
2007-08-11
2008-01-01
DC
US
2,171
0
0
2024-01-30T19:20:32.148908-05:00
BROWNSTEIN HYATT FARBER SCHRECK, LLP
1155 F Street NW, Suite 1200, Washington, DC, 20004, US
7,257
Law firm
QUINN MCKAY
31,842
+1 202-872-5292
null
null
null
null
https://lda.senate.gov/api/v1/clients/109842/
https://lda.senate.gov/api/v1/registrants/7257/
https://lda.senate.gov/filings/public/filing/8f6921d7-41b0-478d-82de-5c834ae5b4f0/print/
8f6921d7-41b0-478d-82de-5c834ae5b4f0
8f6921d7-41b0-478d-82de-5c834ae5b4f0_7257_109842
medical device manufacturers association
2008-04-19T23:16:46
4755
2008-04-21T00:00:00
medical device manufacturers association
null
70,000
a
service_provided
[ "Issues Relating to the Patent Reform Act of 2007 (H.R. 1908/ S.1145)", "Issues relating to Group Purchasing Organizations\nIssues Relating to the Physician Sunshine Act of 2007 (S.2029)\nIssues relating to Transparency in Mecial Device Pricing (S.2221)\nIssues Relating to Comparative Effectiveness", "Issues relating to SBIR Grant", "Issues relating to reimbursement of medical devices", "Issues Relating to Appropriations" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "SMB - Small Business", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "113 - Patent & Trademark Office (PTO)", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "113 - Patent & Trademark Office (PTO)", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "113 - Patent & Trademark Office (PTO)", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "113 - Patent & Trademark Office (PTO)", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "113 - Patent & Trademark Office (PTO)", "1 - SENATE" ]
2008-Q1
2014-02-24
null
DC
US
12
0
1
2024-01-08T15:44:39.815951-05:00
MEDICAL DEVICE MANUFACTURERS ASSOCIATION
1333 H Street NW, Ste 400W, WASHINGTON, DC, 20005, US
24,794
trade association
MR. MARK B. LEAHEY
31,975
+1 202-354-7171
[ "MARK LEAHEY", "THOMAS C NOVELLI", "MARK LEAHEY", "THOMAS C NOVELLI", "MARK LEAHEY", "THOMAS C NOVELLI", "MARK LEAHEY", "THOMAS C NOVELLI", "MARK LEAHEY", "THOMAS C NOVELLI" ]
[ 10041, 46992, 10041, 46992, 10041, 46992, 10041, 46992, 10041, 46992 ]
[ null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/132537/
https://lda.senate.gov/api/v1/registrants/24794/
https://lda.senate.gov/filings/public/filing/bcaf3653-a94d-44f5-9471-cd34d965985b/print/
bcaf3653-a94d-44f5-9471-cd34d965985b
bcaf3653-a94d-44f5-9471-cd34d965985b_24794_132537
medical device manufacturers association
2008-04-21T13:30:58
4755
2008-07-16T00:00:00
medical device manufacturers association
null
20,000
lobbying_income
service_provided
[ "S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.\nIssues related to group purchasing organizations' Medicare Safe Harbor." ]
[ "MMM - Medicare/Medicaid" ]
[ "1 - SENATE" ]
2008-Q2
2007-08-07
null
DC
US
3,693
0
0
2024-04-02T09:42:37.694409-04:00
OGR
1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US
48,827
lobbying firm
RAWSON WARDEN
34,528
+1 202-729-4200
[ "ANDREW ROSENBERG", "JULIE DAMMANN (Chief of Staff, Senator Christopher S. Bond)", "WAYNE BERMAN" ]
[ 37206, 3791, 20506 ]
[ null, "Chief of Staff, Senator Christopher S. Bond", null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/155797/
https://lda.senate.gov/api/v1/registrants/48827/
https://lda.senate.gov/filings/public/filing/3831e406-d17e-4a24-952c-b7b1bb2c5e1c/print/
3831e406-d17e-4a24-952c-b7b1bb2c5e1c
3831e406-d17e-4a24-952c-b7b1bb2c5e1c_48827_155797
medical device manufacturers association
2008-07-16T14:31:26
4755
2008-07-16T00:00:00
medical device manufacturers association
null
15,000
lobbying_income
service_provided
[ "HR 6331-- Medicare Improvements for Patients and Providers Act of 2008\nS.2029-- Physician Payment Sunshine Act of 2007" ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q2
2007-08-08
null
DC
US
36
0
null
2024-04-05T13:54:32.459249-04:00
WALTER CONSULTING
7111 Capitol View Drive, McLean, VA, 22101, US
301,697
Federal health care advocacy
MRS. SARAH WALTER
37,801
+1 202-288-8190
[ "SARAH WALTER" ]
[ 33110 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/180707/
https://lda.senate.gov/api/v1/registrants/301697/
https://lda.senate.gov/filings/public/filing/a2265df2-9e78-4ad8-af22-6567b8de740d/print/
a2265df2-9e78-4ad8-af22-6567b8de740d
a2265df2-9e78-4ad8-af22-6567b8de740d_301697_180707
medical device manufacturers association
2008-07-16T18:25:34
4755
2008-07-17T00:00:00
medical device manufacturers association
null
5,000
lobbying_income
retainer
[]
null
null
2008-Q2
2007-08-14
null
DC
US
1,038
0
null
2022-04-06T16:04:30.396745-04:00
LATHAM & WATKINS LLP
555 11th Street, NW, Suite 1000, Washington, DC, 20004, US
22,201
law firm
EMILY GIBSON
30,855
+1 213-892-3210
null
null
null
null
https://lda.senate.gov/api/v1/clients/129079/
https://lda.senate.gov/api/v1/registrants/22201/
https://lda.senate.gov/filings/public/filing/b4a2faa7-ee55-4fdc-b648-616e4ad3a141/print/
b4a2faa7-ee55-4fdc-b648-616e4ad3a141
b4a2faa7-ee55-4fdc-b648-616e4ad3a141_22201_129079
medical device manufacturers association
2008-07-17T14:39:08
4755
2008-07-17T00:00:00
medical device manufacturers association
null
70,000
a
service_provided
[ "Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to The Physician Sunshine Act (s.2029), Issues relating to Transparency in Medical Device Pricing Act of 2007 (S.2221), Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR", "Issues Relating to the Patent Reform Act (H.R. 1908 / S. 1145)", "Issues relating to reimbursement of Medical Devices", "Issues relating to Appropriations" ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q2
2014-02-24
null
DC
US
12
0
1
2024-01-08T15:44:39.815951-05:00
MEDICAL DEVICE MANUFACTURERS ASSOCIATION
1333 H Street NW, Ste 400W, WASHINGTON, DC, 20005, US
24,794
trade association
MR. MARK B. LEAHEY
31,975
+1 202-354-7171
[ "MARK LEAHEY", "THOMAS C NOVELLI", "MARK LEAHEY", "THOMAS C NOVELLI", "MARK LEAHEY", "THOMAS C NOVELLI", "MARK LEAHEY", "THOMAS C NOVELLI" ]
[ 10041, 46992, 10041, 46992, 10041, 46992, 10041, 46992 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/132537/
https://lda.senate.gov/api/v1/registrants/24794/
https://lda.senate.gov/filings/public/filing/089c572a-348b-489e-9e4b-23f190072144/print/
089c572a-348b-489e-9e4b-23f190072144
089c572a-348b-489e-9e4b-23f190072144_24794_132537
medical device manufacturers association
2008-07-17T15:01:20
4755
2008-09-01T00:00:00
medical device manufacturers association
Trade association for medical device manufacturers
20,000
lobbying_income
service_provided
[ "Opposition to medical device industry tax in H.R. 3962, \"Affordable Health Care for America Act,\" and H.R. 3590, \"Patient Protection and Affordable Care Act.\"" ]
[ "TAX - Taxation/Internal Revenue Code" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q4
2008-09-01
null
DC
US
303
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "JOHN MCMANUS", "NICK SHIPLEY (Legislative Director, Rep. Jay Inslee)" ]
[ 9573, 47494 ]
[ null, "Legislative Director, Rep. Jay Inslee" ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/176447/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/2d800f1e-c358-4ac8-b9a8-198f0801d4d5/print/
2d800f1e-c358-4ac8-b9a8-198f0801d4d5
2d800f1e-c358-4ac8-b9a8-198f0801d4d5_286096_176447
medical device manufacturers association
null
4755
2008-09-01T00:00:00
medical device manufacturers association
Trade association for medical device manufacturers
30,000
lobbying_income
service_provided
[ "FDA approval issues.", "Support for H.R. 436 \"Protect Medical Innovation Act,\" S. 17 \"Medical Device Access and Innovation Protection Act,\" and S. 262 \"A bill to repeal the excise tax on medical device manufacturers.\"" ]
[ "HCR - Health Issues", "TAX - Taxation/Internal Revenue Code" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2011-Q4
2008-09-01
null
DC
US
303
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "JOHN MCMANUS", "NICK SHIPLEY (Legislative Director, Rep. Jay Inslee)", "JOHN MCMANUS", "NICK SHIPLEY (Legislative Director, Rep. Jay Inslee)" ]
[ 9573, 47494, 9573, 47494 ]
[ null, "Legislative Director, Rep. Jay Inslee", null, "Legislative Director, Rep. Jay Inslee" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/176447/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/96b388a3-5fa1-44ec-b46c-1e0c5e6c081e/print/
96b388a3-5fa1-44ec-b46c-1e0c5e6c081e
96b388a3-5fa1-44ec-b46c-1e0c5e6c081e_286096_176447
medical device manufacturers association
null
4755
2008-09-01T00:00:00
medical device manufacturers association
Trade association for medical device manufacturers
30,000
lobbying_income
service_provided
[ "H.R.160 - Protect Medical Innovation Act of 2015 & S.149 - Medical Device Access and Innovation Protection Act", "Issues related to market access." ]
[ "TAX - Taxation/Internal Revenue Code", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q4
2008-09-01
null
DC
US
303
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "JOHN MCMANUS", "BARRETT THORNHILL", "JOHN MCMANUS", "BARRETT THORNHILL" ]
[ 9573, 59333, 9573, 59333 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/176447/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/cfd12047-3d70-410c-9c4b-3269c8730a9f/print/
cfd12047-3d70-410c-9c4b-3269c8730a9f
cfd12047-3d70-410c-9c4b-3269c8730a9f_286096_176447
medical device manufacturers association
null
4755
2008-09-01T00:00:00
medical device manufacturers association
Trade association for medical device manufacturers
30,000
lobbying_income
modify_service
[ "Support for S. 692 - Protection Medical Innovation Act of 2019. Support for H.R. 2207 - To amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices." ]
[ "TAX - Taxation/Internal Revenue Code" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q1
2008-09-01
null
DC
US
303
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "JOHN MCMANUS", "BARRETT THORNHILL", "WILLIAM RHYNE" ]
[ 9573, 59333, 70433 ]
[ null, null, null ]
[ false, false, true ]
https://lda.senate.gov/api/v1/clients/176447/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/96590caf-35d3-4a58-b097-442d825e624d/print/
96590caf-35d3-4a58-b097-442d825e624d
96590caf-35d3-4a58-b097-442d825e624d_286096_176447
medical device manufacturers association
null
4755
2008-10-10T00:00:00
medical device manufacturers association
null
5,000
lobbying_income
retainer
[]
null
null
2008-Q3
2007-08-14
null
DC
US
1,038
0
null
2022-04-06T16:04:30.396745-04:00
LATHAM & WATKINS LLP
555 11th Street, NW, Suite 1000, Washington, DC, 20004, US
22,201
law firm
EMILY GIBSON
30,855
+1 213-892-3210
null
null
null
null
https://lda.senate.gov/api/v1/clients/129079/
https://lda.senate.gov/api/v1/registrants/22201/
https://lda.senate.gov/filings/public/filing/acc21243-9e24-4bb3-ac90-01ac4485413a/print/
acc21243-9e24-4bb3-ac90-01ac4485413a
acc21243-9e24-4bb3-ac90-01ac4485413a_22201_129079
medical device manufacturers association
2008-10-10T20:27:21
4755
2008-10-16T00:00:00
medical device manufacturers association
null
20,000
lobbying_income
service_provided
[ "S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007.\nS.2029, Physician Payments Sunshine Act of 2007. \nIssues related to group purchasing organizations' Medicare Safe Harbor." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2008-Q3
2007-08-07
null
DC
US
3,693
0
0
2024-04-02T09:42:37.694409-04:00
OGR
1111 19th Street, NW, Suite 1100, Washington, DC, 20036, US
48,827
lobbying firm
RAWSON WARDEN
34,528
+1 202-729-4200
[ "ANDREW ROSENBERG", "JULIE DAMMANN (Chief of Staff, Senator Christopher S. Bond)", "WAYNE BERMAN" ]
[ 37206, 3791, 20506 ]
[ null, "Chief of Staff, Senator Christopher S. Bond", null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/155797/
https://lda.senate.gov/api/v1/registrants/48827/
https://lda.senate.gov/filings/public/filing/d04709e3-8cc0-4478-b14f-7ac1f7c39bee/print/
d04709e3-8cc0-4478-b14f-7ac1f7c39bee
d04709e3-8cc0-4478-b14f-7ac1f7c39bee_48827_155797
medical device manufacturers association
2008-10-16T17:50:46